Original ResearchPublished 9 October 2026Cytarabine-based mobilisation yields higher CD34+ cell counts than cyclophosphamide regardless of prior daratumumab exposure in multiple myelomaWojciech Szlasa · Artur Borkowski · Monika Mordak-Domagała · Jacek Kwiatkowski · Katarzyna Malesa · Mateusz Sawicki · Jarosław DybkoFrontiers in Oncologydoi 10.3389/fonc.2026.1915658